Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
Duke University
Radiation Therapy Oncology Group
Dartmouth-Hitchcock Medical Center
St. Jude Children's Research Hospital
NYU Langone Health
Adnexus, A Bristol-Myers Squibb R&D Company